A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Incontinence, Urinary and Urinary Bladder, OveractiveOveractive Bladder
Interventions
DRUG

GW679769 oral tablets

Trial Locations (58)

12205

GSK Investigational Site, Albany

12401

GSK Investigational Site, Kingston

12601

GSK Investigational Site, Poughkeepsie

17604

GSK Investigational Site, Lancaster

18960

GSK Investigational Site, Sellersville

19004

GSK Investigational Site, Bala-Cynwyd

23294

GSK Investigational Site, Richmond

27103

GSK Investigational Site, Winston-Salem

28144

GSK Investigational Site, Salisbury

29681

GSK Investigational Site, Simpsonville

30309

GSK Investigational Site, Atlanta

33024

GSK Investigational Site, Pembroke Pines

33143

GSK Investigational Site, Miami

33156

GSK Investigational Site, Miami

33180

GSK Investigational Site, Aventura

33761

GSK Investigational Site, Clearwater

33916

GSK Investigational Site, Fort Myers

34237

GSK Investigational Site, Sarasota

34474

GSK Investigational Site, Ocala

35801

GSK Investigational Site, Huntsville

37232

GSK Investigational Site, Nashville

40509

GSK Investigational Site, Lexington

46254

GSK Investigational Site, Indianapolis

47130

GSK Investigational Site, Jeffersonville

47630

GSK Investigational Site, Newburgh

60160

GSK Investigational Site, Melrose Park

75234

GSK Investigational Site, Dallas

80012

GSK Investigational Site, Aurora

80210

GSK Investigational Site, Denver

80211

GSK Investigational Site, Denver

80501

GSK Investigational Site, Longmont

85023

GSK Investigational Site, Phoenix

90506

GSK Investigational Site, Torrance

91942

GSK Investigational Site, La Mesa

92404

GSK Investigational Site, San Bernardino

95350

GSK Investigational Site, Modesto

97477

GSK Investigational Site, Springfield

98405

GSK Investigational Site, Tacoma

85381 - 4828

GSK Investigational Site, Peoria

06708

GSK Investigational Site, Waterbury

02906

GSK Investigational Site, Providence

V3V 1N1

GSK Investigational Site, Surrey

V8T 5G1

GSK Investigational Site, Victoria

V8V 3N1

GSK Investigational Site, Victoria

E3B 5B8

GSK Investigational Site, Fredericton

E2L 4L2

GSK Investigational Site, Saint John

B4N 4K9

GSK Investigational Site, Kentville

B2N 1L2

GSK Investigational Site, Truro

L4M 7G1

GSK Investigational Site, Barrie

N2M 5N4

GSK Investigational Site, Kitchener

L3X 1W1

GSK Investigational Site, Newmarket

P1B 4Z2

GSK Investigational Site, North Bay

L6H 3P1

GSK Investigational Site, Oakville

M6A 3B5

GSK Investigational Site, Toronto

J4V 2H3

GSK Investigational Site, Greenfield Park

H9R 4S3

GSK Investigational Site, Pointe-Claire

G1S 2L6

GSK Investigational Site, Québec

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY